New scaffold device tested to save legs in High-Risk patients
NCT ID NCT07465627
First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 3 times
Summary
This study tests a new device called the Spur scaffold, used with a drug-coated balloon, to treat blocked arteries below the knee in people with chronic limb-threatening ischemia (CLTI). The study includes 40 high-risk patients—those with diabetes or on dialysis—and measures how much the artery recoils (shrinks back) within 15 minutes after treatment. The goal is to see if this approach works better for these difficult-to-treat patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Spur Peripheral Retrievable Scaffold System with a drug-coated balloon
- What this could lead to
- If successful, this could help doctors understand how to better treat blocked leg arteries in high-risk patients, potentially reducing amputations.
- What could go wrong
- This is a very small, early study (40 people) that only measures immediate vessel recoil, not long-term outcomes. It may not lead to better treatments or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIMB-THREATENING ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Graz, Division of Angiology
RECRUITINGGraz, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a sound wave camera inside arteries save more legs?
- Can frailty predict stent failure? new study investigates
- New balloon coated with drug could save limbs in severe artery disease
- New ultrasound technique aims to save limbs in artery disease patients
- Blood thinner duration trial aims to save limbs in severe artery disease
- New device aims to prevent amputation in patients with no other options